This is the recording of the regular press briefing of European Medicines Agency on COVID-19 vaccines and therapeutics that took place on 5 October 2021.
00:00 Introduction
01:32 Update on recent developments (as of 05.10.2021) by Dr. Cavaleri
11:44 Questions from journalists
12:30 Booster dose of COVID-19 vaccine
15:03 Treatments developed by Merck
16:25 Janssen vaccine
18:03 Booster doses in different EU countries
20:39 Monoclonal antibodies: rolling review and assessment
23:57 How long a third dose of vaccine may last?
25:26 Criteria for application of the booster
27:15 EMA and European Commission
28:04 Immunogenicity data
29:33 Wrap-up
EMA Speakers:
Marco Cavaleri, Head of Biological Health Threats and Vaccines Strategy
Fergus Sweeney, Head of Clinical Studies and Manufacturing Task Force
Georgy Genov, Head of Pharmacovigilance
#EMAPresser #COVID19
EMA press briefing 5 October 2021
Теги
covid19covid-19omicronemafdavaccinesEMAPresserpressbriefingjournalistsicknesstreatmentanti-viralvariantconcernprotectionboosterhospitalisationthirddoseshotjabmRNAvectorvulnerablefragilestrategyvaccinationpandemicendemicexposureimmunityimmune systemimmune responseregulatormedicinesmarketing authorisationdataevidencepopulationeffectivenessvaccinemerckthird dosemonoclonalantibodiesantiviralsImmunogenicityJanssencriteria